| Time | Text |
|---|---|
|
Biden Vaccine Contract Halted
00:03:47
|
|
| Trump's HHS halts multi-million dollar Biden era contract to create a new COVID-19 vaccine. | |
| So you had RFK Jr. has halted a Biden era contract to create this new vaccine. | |
| He says, quote, Now, keep that in mind. | |
| That isn't just a shot at the Biden administration. | |
| This is absolute truth. | |
| There was literally no oversight for monies or research when it came to COVID jabs, COVID vaccines as well. | |
| As well as virtually everything else is what we're finding out now through all of the things that are being exposed through Doge. | |
| RFK Jr. goes on. | |
| Quote. | |
| I look forward to working with VaxArt and medical experts to ensure this work produces safe, effective, and fiscal-minded vaccine technology. | |
| Now, that's some of the things that we've been wanting all along. | |
| Is it fiscally responsible? | |
| Is it safe? | |
| Is it effective? | |
| Is it really a vaccine? | |
| Or is it a therapeutic, which many of these so-called vaccines turned out to be? | |
| The HHS contract, according to Breitbart, is with American biotech company VaxArt. | |
| Which has been developing a new COVID-19 vaccine that is taken orally. | |
| So Kennedy didn't terminate the contract, for all of you out there. | |
| Instead, the trial is paused. | |
| It's a 90-day pause to stop the work order, and that was issued on Friday. | |
| The stop work order came ahead at the beginning of clinical trials on Monday with 10,000 individuals. | |
| So no oversight by the federal government. | |
| 10,000 individuals that were going to be lab rats for this vaccine and it had not been reviewed by the Department of Health and Human Services. | |
| You got that? | |
| The contract is part of the Biden administration's $4.7 billion Project Next Generation Initiative, which it launched in 2023. They did so in order to streamline the development of new vaccines, according to the report. | |
| The VaxArt vaccine is funded through an agreement with BARDA. BARDA, B-A-R-A-D-A, is an acronym, and that stands for Biomedical Advanced Research and Development Authority. | |
| That comes under the Department and the Administration for Strategic Preparedness and Response within the HHS. BARDA had obligated $460 million for the development of VaxArt's COVID-19 vaccine. | |
| $240 million had already been dispersed for the preliminary study. | |
| However, the stop work order prevents VaxArt from invoicing BARDA. Basically, within the HHS, the remaining $230 million for clinical trials until further notice. | |
| According to the report, VaxArt is still able to invoice HHS for medical monitoring of the people who took part in early trials. | |
| The pause comes less than two weeks after Kennedy's confirmation. | |
|
How Was $490 Million Secured?
00:00:28
|
|
| All right, so this is a good thing. | |
| I mean, we're going to be spending all this money for vaccines, and there's no telling. | |
| Let's be honest. | |
| There's no telling how these people, VaxArt, and listen, I simply don't know. | |
| I'm not accusing VaxArt of anything, but do we know how these people were able to secure that money from the federal government? | |
| $490 million, more than half of it being paid out already? | |